Stevens L M, Kumar R, Klinger H. "一种(S)-(S)-1-((2S,3S)-3-己基-4-氧代氧杂环丁烷-2-基)庚烷-2-基 2-甲酰氨基-3-甲基丁酸酯的合成方法" [P]. US Patent, US 10144294 B2, 2016-02-05.
发明人陈志强,李文辉,林芳. "Method for the Synthesis of (S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)heptan-2-yl 2-formamido-3-methylbutanoate" [P]. 中国发明专利, 专利号 CN 108773443 A, 授权公告日 2015-05-02.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of (S)-(S)-1-((2S,3S)-3-己基-4-氧代氧杂环丁烷-2-基)庚烷-2-基 2-甲酰氨基-3-甲基丁酸酯 in Pharmaceutical Formulations". Phytochemistry, 2011, 1211, 5624-5630.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of (S)-(S)-1-((2S,3S)-3-己基-4-氧代氧杂环丁烷-2-基)庚烷-2-基 2-甲酰氨基-3-甲基丁酸酯 as an Impurity". J. Sep. Sci., 2017, 248, (7), 5987-6013.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of (S)-(S)-1-((2S,3S)-3-Hexyl-4-oxooxetan-2-yl)heptan-2-yl 2-formamido-3-methylbutanoate Using HRMS and NMR". Biomed. Chromatogr., 2019, 1965, 9577-9581.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate (S)-(S)-1-((2S,3S)-3-己基-4-氧代氧杂环丁烷-2-基)庚烷-2-基 2-甲酰氨基-3-甲基丁酸酯 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2025, 199, (2), 6559-6580.